AL
TME Pharma N.V.
ALTME.PA · PAR
0.10 € +3.79% (+0.00 €)
1M +31.84%
Market Cap 10.1M €
P/E Ratio -
Div. Yield -
ROE 1,273.26%
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 270.01%
ROE 1,273.26%
Asset turnover 0.00x
Debt
5 /100
High Current ratio 0.57x
Int. coverage -2.67x
Debt/Equity N/A
Stability
80 /100
Stable Beta 0.61x
EPS volatility 3.34%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALTME.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Diede van den Ouden
Employees
12
Headquarters
Berlin